Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03589261
Other study ID # PI2018_843_0006
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 6, 2018
Est. completion date March 29, 2019

Study information

Verified date April 2019
Source Centre Hospitalier Universitaire, Amiens
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Hepatic artery and portal flows are both regulated to assume the whole hepatic blood flow. Each counts for respectively 25% and 75%. That so-called "buffer response" assumes that when portal flow increases, hepatic artery flow decreases. During fluid challenge in intensive care unit, fluid challenge is often administered to improve hepatic perfusion. That observation is not demonstrated. The aim of the study is to test buffer response and portal flow during fluid challenge.


Description:

Prospective monocentric study at Amiens Hospital University. 20 volunteers subjects will be include after providing informed consent. Fluid challenge will be performed with 500 ml of intra venous NaCl (0.9%). Hepatic blood flow measurement will be performed using MRI.


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date March 29, 2019
Est. primary completion date March 29, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria:

- Fasting for the last 12 hours.

Exclusion Criteria:

- Claustrophobia

- Any previous medical history disease;

- Any abdominal surgical disease

- Pregnancy or breastfeeding

Study Design


Related Conditions & MeSH terms


Intervention

Device:
MRI (magnetic resonance imaging)
Fluid challenge will be performed with 500 ml of intra venous NaCl (0.9%). Hepatic blood flow measurement will be performed using MRI.

Locations

Country Name City State
France CHU Amiens-Picardie Amiens

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire, Amiens

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Other Flow ratio of portal flow on hepatic artery flow Flow ratio of portal flow on hepatic artery flow before and after a volume expansion of 500 ml NaCl 0.9%. Two hours
Primary Portal blood flow measure before and after fluid challenge Fluid challenge will be performed with 500 ml of intra venous NaCl (0.9%). Hepatic blood flow measurement will be performed using MRI (magnetic resonance imaging). Two hours: the difference in hepatic portal flow before and after a volume expansion of 500 ml NaCl 0.9%.
Secondary Hepatic artery blood flow measure before and after fluid challenge Hepatic artery blood flow measure before and after a volume expansion of 500 ml NaCl 0.9%. Two hours